Investigation of the influence of two low-dose monophasic oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, on lipid metabolism in an open randomized trial
- 30 November 1996
- journal article
- Published by Elsevier in Contraception
- Vol. 54 (5), 291-297
- https://doi.org/10.1016/s0010-7824(96)00182-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Progestins and oral contraceptive-induced lipoprotein changes: A prospective studyContraception, 1986
- The Effects of Estrogen Administration on Plasma Lipoprotein Metabolism in Premenopausal FemalesJournal of Clinical Endocrinology & Metabolism, 1983
- Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein CholesterolNew England Journal of Medicine, 1983
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENTThe Lancet, 1980
- Cholesterol in the Prediction of Atherosclerotic DiseaseAnnals of Internal Medicine, 1979
- The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart diseaseEuropean Journal of Clinical Investigation, 1978
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- THE TROMSØHEART-STUDYThe Lancet, 1977